Immatics N.V. SEC filings IMTX
Immatics N.V. has 243 filings in SEC EDGAR's recent list, going back to Apr 16, 2020. Its latest annual report, Form 20-F, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 26, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 26, 2026 | Oct 24, 2026 |
| 6-K | Current report (foreign issuer) | Oct 23, 2026 | Oct 23, 2026 |
| 4 | Insider transaction | Aug 27, 2026 | Aug 26, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 27, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 26, 2026 | Aug 26, 2026 |
| 424B2 | Prospectus | Aug 25, 2026 | — |
| 4 | Insider transaction | Aug 18, 2026 | Aug 14, 2026 |
| 6-K | Current report (foreign issuer) | Aug 18, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 3 | Initial insider ownership | Jul 29, 2026 | Jul 20, 2026 |
| S-8 | Employee stock plan registration | Jun 25, 2026 | — |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 6-K | Current report (foreign issuer) | Jun 18, 2026 | Jun 18, 2026 |
| 6-K | Current report (foreign issuer) | Jun 2, 2026 | Jun 2, 2026 |
| 6-K | Current report (foreign issuer) | Jun 1, 2026 | Jun 1, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 6-K | Current report (foreign issuer) | May 12, 2026 | May 12, 2026 |
| 6-K | Current report (foreign issuer) | Apr 21, 2026 | Apr 21, 2026 |
| 6-K | Current report (foreign issuer) | Apr 17, 2026 | Apr 17, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 17, 2026 | Mar 17, 2026 |
| 20-F | Annual report (foreign issuer) | Mar 5, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 5, 2026 | Mar 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 12, 2026 | Jan 12, 2026 |
| 6-K | Current report (foreign issuer) | Dec 11, 2025 | Dec 11, 2025 |
| 6-K | Current report (foreign issuer) | Dec 8, 2025 | Dec 8, 2025 |
| 424B5 | Prospectus supplement | Dec 5, 2025 | — |
| 424B5 | Prospectus supplement | Dec 5, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 17, 2025 | Nov 17, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 12, 2025 | Nov 12, 2025 |
| 6-K | Current report (foreign issuer) | Oct 27, 2025 | Oct 27, 2025 |
| 6-K | Current report (foreign issuer) | Oct 20, 2025 | Oct 20, 2025 |
| 6-K | Current report (foreign issuer) | Oct 1, 2025 | Oct 1, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| 6-K | Current report (foreign issuer) | Aug 13, 2025 | Jun 30, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2025 | — |
| S-8 | Employee stock plan registration | Jul 2, 2025 | — |
| 25-NSE | Delisting notice | Jul 1, 2025 | — |
| 6-K | Current report (foreign issuer) | Jun 18, 2025 | Jun 18, 2025 |
| 6-K | Current report (foreign issuer) | Jun 2, 2025 | Jun 2, 2025 |
| 6-K | Current report (foreign issuer) | Jun 2, 2025 | Jun 2, 2025 |
| 6-K | Current report (foreign issuer) | May 13, 2025 | May 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 2, 2025 | — |
| EFFECT | Filing | Apr 3, 2025 | — |
| CORRESP | Letter to the SEC | Apr 1, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 1, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 27, 2025 | — |
| 6-K | Current report (foreign issuer) | Mar 27, 2025 | Mar 27, 2025 |
| 20-F | Annual report (foreign issuer) | Mar 27, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 7, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 11, 2025 | — |
| 6-K | Current report (foreign issuer) | Jan 13, 2025 | Jan 13, 2025 |
| 6-K | Current report (foreign issuer) | Dec 13, 2024 | Dec 13, 2024 |
| 6-K | Current report (foreign issuer) | Nov 18, 2024 | Nov 18, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| 6-K | Current report (foreign issuer) | Nov 8, 2024 | Nov 8, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 17, 2024 | — |
| 6-K | Current report (foreign issuer) | Oct 15, 2024 | Oct 15, 2024 |
| 424B2 | Prospectus | Oct 11, 2024 | — |
| 424B2 | Prospectus | Oct 10, 2024 | — |
| F-3ASR | Filing | Oct 10, 2024 | — |
| 6-K | Current report (foreign issuer) | Oct 10, 2024 | Oct 10, 2024 |
| 6-K | Current report (foreign issuer) | Sep 16, 2024 | Sep 16, 2024 |
| 6-K | Current report (foreign issuer) | Aug 13, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | Jul 31, 2024 | Jul 29, 2024 |
| S-8 | Employee stock plan registration | Jul 22, 2024 | — |
| 6-K | Current report (foreign issuer) | Jun 20, 2024 | Jun 20, 2024 |
| SC 13D | Ownership over 5% (active) | Jun 6, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jun 6, 2024 | — |
| 6-K | Current report (foreign issuer) | Jun 3, 2024 | May 30, 2024 |
| 6-K | Current report (foreign issuer) | May 14, 2024 | May 14, 2024 |
| 6-K | Current report (foreign issuer) | Mar 21, 2024 | Mar 21, 2024 |
| 20-F | Annual report (foreign issuer) | Mar 21, 2024 | Dec 31, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 8, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 7, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 7, 2024 | — |
| 6-K | Current report (foreign issuer) | Jan 22, 2024 | Jan 22, 2024 |
| 424B5 | Prospectus supplement | Jan 19, 2024 | — |
| 424B5 | Prospectus supplement | Jan 17, 2024 | — |
| 6-K | Current report (foreign issuer) | Nov 14, 2023 | Nov 14, 2023 |
| 6-K | Current report (foreign issuer) | Nov 8, 2023 | Nov 8, 2023 |
| 6-K | Current report (foreign issuer) | Oct 24, 2023 | Oct 24, 2023 |
| EFFECT | Filing | Sep 13, 2023 | — |
| 424B3 | Prospectus | Sep 13, 2023 | — |
| CORRESP | Letter to the SEC | Sep 11, 2023 | — |
| 6-K | Current report (foreign issuer) | Sep 11, 2023 | Sep 11, 2023 |
| UPLOAD | Letter from the SEC | Aug 29, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 25, 2023 | — |
| 6-K | Current report (foreign issuer) | Aug 17, 2023 | Jun 30, 2023 |
| SC 13G | Ownership over 5% (passive) | Aug 16, 2023 | — |
| 6-K | Current report (foreign issuer) | Aug 10, 2023 | Aug 10, 2023 |
| 6-K | Current report (foreign issuer) | Jul 24, 2023 | Jun 24, 2023 |
| 6-K | Current report (foreign issuer) | Jun 20, 2023 | Jun 20, 2023 |
| 6-K | Current report (foreign issuer) | May 26, 2023 | May 23, 2023 |
| 6-K | Current report (foreign issuer) | May 16, 2023 | May 16, 2023 |
| 6-K | Current report (foreign issuer) | May 2, 2023 | May 2, 2023 |
| 6-K | Current report (foreign issuer) | May 1, 2023 | May 1, 2023 |
| 20-F | Annual report (foreign issuer) | Mar 22, 2023 | Dec 31, 2022 |
| 6-K | Current report (foreign issuer) | Mar 21, 2023 | Mar 22, 2023 |
| 6-K | Current report (foreign issuer) | Mar 13, 2023 | Mar 13, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 7, 2023 | — |
| 6-K | Current report (foreign issuer) | Jan 9, 2023 | Jan 9, 2023 |
| 6-K | Current report (foreign issuer) | Nov 17, 2022 | Nov 17, 2022 |
| 6-K | Current report (foreign issuer) | Nov 10, 2022 | Nov 10, 2022 |
| 6-K | Current report (foreign issuer) | Oct 18, 2022 | Oct 18, 2022 |
| 6-K | Current report (foreign issuer) | Oct 12, 2022 | Oct 12, 2022 |
| 424B5 | Prospectus supplement | Oct 11, 2022 | — |
| 424B5 | Prospectus supplement | Oct 11, 2022 | — |
| 6-K | Current report (foreign issuer) | Oct 11, 2022 | Oct 11, 2022 |
| 6-K | Current report (foreign issuer) | Sep 12, 2022 | Sep 12, 2022 |
| 6-K | Current report (foreign issuer) | Aug 23, 2022 | Aug 23, 2022 |
| 6-K | Current report (foreign issuer) | Aug 9, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Jun 30, 2022 | Jun 30, 2022 |
| S-8 | Employee stock plan registration | Jun 24, 2022 | — |
| 6-K | Current report (foreign issuer) | Jun 14, 2022 | Jun 14, 2022 |
| 6-K | Current report (foreign issuer) | Jun 13, 2022 | Jun 13, 2022 |
| 6-K | Current report (foreign issuer) | Jun 7, 2022 | Jun 7, 2022 |
| 6-K | Current report (foreign issuer) | Jun 2, 2022 | Jun 2, 2022 |
| 6-K | Current report (foreign issuer) | Jun 2, 2022 | Jun 2, 2022 |
| 6-K | Current report (foreign issuer) | May 27, 2022 | May 27, 2022 |
| 6-K | Current report (foreign issuer) | May 18, 2022 | May 18, 2022 |
| 6-K | Current report (foreign issuer) | May 10, 2022 | May 10, 2022 |
| 20-F | Annual report (foreign issuer) | Mar 23, 2022 | Dec 31, 2021 |
| 6-K | Current report (foreign issuer) | Mar 23, 2022 | Mar 23, 2022 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2022 | — |
| 6-K | Current report (foreign issuer) | Dec 14, 2021 | Dec 14, 2021 |
| 6-K | Current report (foreign issuer) | Nov 16, 2021 | Nov 16, 2021 |
| 6-K | Current report (foreign issuer) | Nov 9, 2021 | Nov 9, 2021 |
| 6-K | Current report (foreign issuer) | Nov 1, 2021 | Nov 1, 2021 |
| 6-K/A | Filing | Oct 28, 2021 | Oct 28, 2021 |
| 6-K/A | Filing | Oct 28, 2021 | Oct 28, 2021 |
| 20-F/A | Amended annual report (foreign issuer) | Oct 28, 2021 | Dec 31, 2020 |
| 6-K | Current report (foreign issuer) | Aug 10, 2021 | Aug 10, 2021 |
| EFFECT | Filing | Aug 9, 2021 | — |
| CORRESP | Letter to the SEC | Aug 6, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 6, 2021 | — |
| EFFECT | Filing | Aug 5, 2021 | — |
| POS AM | Form pos am | Aug 2, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 2, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 30, 2021 | — |
| CORRESP | Letter to the SEC | Jul 21, 2021 | — |
| 6-K | Current report (foreign issuer) | Jul 15, 2021 | Jul 15, 2021 |
| UPLOAD | Letter from the SEC | Jul 1, 2021 | — |
| 424B3 | Prospectus | Jun 22, 2021 | — |
| 6-K | Current report (foreign issuer) | Jun 22, 2021 | Jun 22, 2021 |
| 424B3 | Prospectus | May 26, 2021 | — |
| 6-K | Current report (foreign issuer) | May 26, 2021 | May 26, 2021 |
| 424B3 | Prospectus | May 18, 2021 | — |
| 6-K | Current report (foreign issuer) | May 18, 2021 | May 18, 2021 |
| 424B3 | Prospectus | May 11, 2021 | — |
| 6-K | Current report (foreign issuer) | May 11, 2021 | May 11, 2021 |
| EFFECT | Filing | Apr 2, 2021 | — |
| 6-K | Current report (foreign issuer) | Apr 1, 2021 | Apr 1, 2021 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IMTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Tubingen, Germany
- SEC filer status
- Accelerated filer
- SEC CIK
- 1809196
- Former names
- Immatics B.V. (until Jul 8, 2020)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.